Jonathan Edwards
Senior Member (Voting Rights)
Does anyone know if Robert Phair has published his idea on an alpha interferon positive feedback cycle? I have seen the videos but did not hit a published paper on this yet.
However, the itaconate shunt hypothesis, developed by Phair, Armstrong, and Davis, proposes the itaconate pathway does not turn of in individuals with ME/CFS [74–77]. It is proposed that in ME/CFS patients the itaconate pathway is not turned on in every cell, but perhaps macrophages, monocytes, and muscle cells. Furthermore, the more cells which are activated, the more severe the ME/CFS symptoms [74–77]
74. Open Medicine Foundation. Rob Phair, PhD, Presents on the Itaconate Shunt Hypothesis for ME/CFS. 2022. p. https://www.youtube.com/watch?v=RiVDNhg4l48.
75. Open Medicine Foundation. NEW Update from Ron Davis: The Itaconate Pathway! In: Open Medicine Foundation, editor. YouTube; 2022. p.15.
76. Open Medicine Foundation. Is ME/CFS Curable? Ronald W. Davis’ Lecture at the 2023 Fatigatio Symposium. 2023. p. 11:29.
77. Open Medicine Foundation. Itaconate Shunt Hypothesis Part 2: Interview with Robert Phair and Janet Dafoe. 2023.
I meant knock down in the sense of a knock down argument to which there is no rebuttal. Not a knock-down or out mouse! Hopefully knocking your socks off too.
It is the step involving B cells (i.e. antibody) that I think may well be wrong; the rest of it looks to me a fairly good bet - but that draws in lots of ideas we have all been playing with for a while. In a way the hypothesis is an attempt to see if all the pieces can be drawn together with one extra step. That may turn out to be the lime slice in the Corona that you never actually ingest. The solution may turn out to be possible without it but the extra step adds a bit of extra zing to the theorising.
I sent him an email w link to this thread.. maybe he’ll come back.Also Robert Phair, although we haven't seen him on the forum for a while @RDP
Very clear thank you. Just one more question - when you say solution here, do you mean the sort of biological-mechanical solution to the 'problem' of ME/CFS, i.e. what the pathway/processes that cause it are, or the solution as in an effective treatment?
My bad for misleading you @V.R.T.!Very clear thank you. Just one more question - when you say solution here, do you mean the sort of biological-mechanical solution to the 'problem' of ME/CFS, i.e. what the pathway/processes that cause it are, or the solution as in an effective treatment?
I sent him an email w link to this thread.. maybe he’ll come back.
Did you watch the 2023 video from the NIH webcast (post about it)? Testing results showed no difference in Interferon-alpha (at 1 hr 10 mins) but they could have more recent data.Does anyone know if Robert Phair has published his idea on an alpha interferon positive feedback cycle? I have seen the videos but did not hit a published paper on this yet.
I don't know if this thread is the right place or not but @paulendat mentioned that ACOD1/IRG1/Itaconate is highly expressed in microglial cells.
So, the cycle is (I think?)
- Pathogen or damage associated molecular patterns (PAMPs and DAMPs) increase IRG1 expression
- That increases itaconate levels in the immune cell
- That reduces levels of PRDX5 (which would normally be mopping up ROS including H2O2)
- So, there is more H2O2
- That results in more interferon being released by the cell
- Interferons can increase itaconate in other immune cells
My intuition keeps pushing me to the idea that metabolic regulation in innate immune cells is precisely that "railway switch". It seems that several TCA cycle metabolites (malate, succinate, citrate, etc.) have dual properties as intermediaries in many of the relevant signaling pathways. It's already been shown that effector function in T cells and activation in macrophages is accompanied by a switch towards increased glycolysis--my question is whether this switch is upstream or downstream of the signaling pathways themselves. And if so, could dysfunction at the metabolic "switch point" maintain the positive feedback loop?The other thought was about positive feedback cycles and 'sticking'.
We spent several months working through feedback routes in RA and came to the conclusion that what is likely to produce an acquired, chronic but unpredictably fluctuating illness is a regulatory system that has 'railway points' between positive and negative feedback loops. Positive feedback that is exhausted by removal of danger signal is everywhere. It is used to amplify but also to localise - to concentrate in one place. But to get the disease dynamics we see we thought you needed a pathway that forked either to positive return or to negative return. Complement and antibody systems do this brilliantly. T cells could do. I still find it hard to think of a way that innate cells will do this, but that may just be that I haven't thought hard enough.
Hutan made a correction after paulendat's comment and it looks like everything else is correct to meI am not well enough to be able to read/study the thread & dont have a science background anyway, but am skimming, & its so heartening to watch you clever people!
But can someone tell me if this summary of the ideas so far by Hutan is accurate please as not seen it confirmed
thanks, so would it be the interferon that is (indirectly) causing the flu-like symptoms then?Hutan made a correction after paulendat's comment and it looks like everything else is correct to me
I see your point here. [Edit: My intuition tells me] that metabolism has to be playing a role. Whether it's mediated through microglia specifically, I'm not sure.One reason for thinking this way is that flu-like symptoms can often be significantly relieved instantly by simple counter-stimuli. Overwhelming nausea can be relieved immediately by vomiting. A sense of oppressive heat can be relieved by a cold cloth on the forehead. I think these symptoms are ultimately neural and can be switched off in seconds, if only partially and temporarily, with other neural inputs. The same sort of thing applies to sleepiness and wakefulness (nucleus caeruleus and RAS).